| Active substance |
Cabergolina |
| Also known as |
Cabaser |
| Blood pressure |
May cause hypotension |
| Chemical name |
Cabergoline |
| Dosage (medical) |
Typically 0.5 mg per week, may vary based on condition |
| Dosage (sports) |
Not specified or recommended for sports use |
| Effects |
Reduces prolactin levels, may help treat symptoms associated with hyperprolactinemia |
| Formula |
C26H37N5O2 |
| Half-life |
63 to 69 hours |
| Hepatotoxicity |
Low risk, but liver function tests are recommended |
| Lab Test |
Prolactin levels, liver function tests |
| Main action |
Inhibition of prolactin secretion |
| Side effects |
Nausea, headache, dizziness, orthostatic hypotension |
| Storage conditions |
Store at room temperature, protect from light and moisture |
| Substance class |
Ergoline derivative, Dopamine D2 receptor agonist |
| Trade name |
Dostinex |
| Use in sports |
Not officially sanctioned, possibly used to control side effects of anabolic steroids |
| Water Retention |
No |
| Active ingredient, mg |
0,5 |
| Release form |
Pills |
| 1 Pill, mg |
0,5 |
| Manufacturer |
Pfizer Labs |
| Packing |
1 pill, Packing (8 Pills) |
